Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-04

FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved BluePoint Laboratories' supplemental application for clonidine hydrochloride (ANDA), granting a supplemental approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLONIDINE HYDROCHLORIDE (Clonidine hydrochloride)

Snippet

SUPPL AP for CLONIDINE HYDROCHLORIDE (CLONIDINE HYDROCHLORIDE)